Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.400 | None | 0.992 | 11 | 0 | 2000 | 2020 | ||||||||
|
ATP binding cassette subfamily D member 1 | 0.563 | 0.731 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATP binding cassette subfamily G member 1 | 0.560 | 0.692 | 0.11 |
|
disease | 0.100 | None | 0.958 | 1 | 0 | 2008 | 2020 | ||||||||
|
angiotensin I converting enzyme 2 | 0.477 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2000 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.400 | None | 0.989 | 8 | 0 | 2003 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.600 | None | 0.974 | 3 | 0 | 1999 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
disease | 0.100 | None | 0.950 | 2 | 0 | 2001 | 2019 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
disease | 0.070 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
aldo-keto reductase family 1 member B10 | 0.546 | 0.769 | 7.6E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.100 | None | 0.947 | 1 | 0 | 2004 | 2019 | ||||||||
|
arachidonate 15-lipoxygenase | 0.502 | 0.846 | 1.1E-23 |
|
disease | 0.400 | None | 0.913 | 3 | 0 | 2004 | 2019 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
disease | 0.400 | None | 0.950 | 1 | 0 | 2003 | 2019 | ||||||||
|
amyloid P component, serum | 0.531 | 0.808 | 3.2E-02 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
disease | 0.100 | None | 0.941 | 4 | 0 | 1983 | 2020 | ||||||||
|
apolipoprotein A4 | 0.582 | 0.577 | 5.5E-06 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1994 | 2019 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
disease | 0.090 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.100 | None | 0.989 | 1 | 0 | 1986 | 2019 | ||||||||
|
apolipoprotein B receptor | 0.792 | 0.231 | 9.4E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
apolipoprotein C1 | 0.581 | 0.577 | 0.22 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
disease | 0.100 | None | 0.955 | 1 | 0 | 1983 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.400 | None | 0.978 | 10 | 0 | 1983 | 2020 | ||||||||
|
apolipoprotein H | 0.563 | 0.769 | 1.6E-15 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2004 | 2019 | ||||||||
|
BMP/retinoic acid inducible neural specific 3 | 0.695 | 0.308 | 0.15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 |